| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | 122 | $5.04B | +$658M | -$494M | +$164M | NUVL, VTRS, NBIX, CNC, OSCR | 13F-HR | 5/15/2025, 04:00 PM |
| Q4 2024 | 105 | $5.26B | +$520M | -$1.12B | -$597M | NUVL, VTRS, CNC, OSCR, RVMD | 13F-HR | 2/14/2025, 04:00 PM |
| Q3 2024 | 443 | $6.69B | +$890M | -$1.14B | -$247M | NUVL, VTRS, CNC, MRUS, OSCR | 13F-HR | 11/14/2024, 04:01 PM |
| Q2 2024 | 433 | $6.01B | +$1.12B | -$578M | +$543M | NUVL, VTRS, CNC, MRUS, LRMR | 13F-HR | 8/14/2024, 04:30 PM |
| Q1 2024 | 367 | $5.75B | +$889M | -$1.21B | -$321M | NUVL, VTRS, CNC, LRMR, AHCO | 13F-HR | 5/15/2024, 04:00 PM |
| Q4 2023 | 222 | $5.42B | +$583M | -$688M | -$106M | NUVL, VTRS, CPRX, CNC, NBIX | 13F-HR | 2/14/2024, 04:01 PM |
| Q3 2023 | 88 | $4.54B | +$651M | -$733M | -$81.1M | NUVL, VTRS, CNC, NBIX, AHCO | 13F-HR | 11/14/2023, 04:01 PM |
| Q2 2023 | 101 | $4.68B | +$468M | -$720M | -$252M | NUVL, VTRS, AMED, AHCO, NBIX | 13F-HR | 8/14/2023, 04:23 PM |
| Q1 2023 | 106 | $4.49B | +$727M | -$907M | -$179M | NUVL, NBIX, CPRX, VTRS, AHCO | 13F-HR | 5/15/2023, 04:00 PM |
| Q4 2022 | 104 | $4.83B | +$1.03B | -$1.35B | -$321M | NUVL, NBIX, AHCO, VTRS, CPRX | 13F-HR | 2/14/2023, 04:11 PM |
| Q3 2022 | 126 | $5.01B | +$932M | -$1.16B | -$225M | NUVL, NBIX, AHCO, SILK, CMAX | 13F-HR | 11/14/2022, 04:27 PM |
| Q2 2022 | 123 | $4.75B | +$1.03B | -$307M | +$724M | NUVL, VTRS, AHCO, NBIX, SILK | 13F-HR | 8/15/2022, 04:53 PM |
| Q1 2022 | 118 | $4.44B | +$744M | -$486M | +$258M | NUVL, VTRS, AHCO, NBIX, CMAX | 13F-HR | 5/16/2022, 04:50 PM |
| Q4 2021 | 125 | $4.75B | +$799M | -$636M | +$163M | NUVL, VTRS, AHCO, CMAX, NBIX | 13F-HR | 2/14/2022, 05:06 PM |
| Q3 2021 | 132 | $5.11B | +$1.09B | -$961M | +$130M | NUVL, VTRS, AHCO, CMAX, NBIX | 13F-HR | 11/15/2021, 04:53 PM |
| Q2 2021 | 143 | $5.63B | +$2.14B | -$1.11B | +$1.03B | VTRS, OMIC, CMAX, AHCO, ORGO | 13F-HR | 8/16/2021, 04:27 PM |
| Q1 2021 | 133 | $4.76B | +$2.34B | -$2.25B | +$83.1M | VTRS, EWTX, CNC, BSX, DFPH | 13F-HR | 5/17/2021, 04:26 PM |
| Q4 2020 | 129 | $5.06B | +$2.59B | -$2.25B | +$333M | VTRS, GRAY, CNC, AFIB, LRMR | 13F-HR | 2/16/2021, 04:23 PM |
| Q3 2020 | 105 | $4.11B | +$1.68B | -$1.26B | +$425M | MYL, IMMU, HZNP, AFIB, DFPHU | Restatement | 12/30/2020, 04:23 PM |
| Q2 2020 | 93 | $3.43B | +$872M | -$1.47B | -$593M | MYL, SDGR, DFPHU, HZNP, IMMU | 13F-HR | 8/14/2020, 04:39 PM |
| Q1 2020 | 90 | $3.14B | +$1.13B | -$623M | +$507M | AHCO, MYL, HZNP, DFPHU, CNC | 13F-HR | 5/15/2020, 04:13 PM |
| Q4 2019 | 75 | $3.13B | +$691M | -$671M | +$19.4M | AHCO, HZNP, MYL, ORTX, FIXX | 13F-HR | 2/14/2020, 04:03 PM |
| Q3 2019 | 94 | $2.45B | +$326M | -$417M | -$90.4M | HZNP, MYL, ORTX, FIXX, AERI | 13F-HR | 11/14/2019, 04:05 PM |
| Q2 2019 | 96 | $2.78B | +$832M | -$511M | +$321M | HZNP, MYL, ORTX, FIXX, AERI | 13F-HR | 8/14/2019, 04:06 PM |
| Q1 2019 | 93 | $2.61B | +$313M | -$544M | -$231M | HZNP, FIXX, ORTX, PTLA, MYL | 13F-HR | 5/15/2019, 04:31 PM |
| Q4 2018 | 98 | $2.46B | +$570M | -$460M | +$110M | HZNP, ORTX, FIXX, MYL, VCEL | 13F-HR | 2/14/2019, 04:05 PM |
| Q3 2018 | 102 | $2.75B | +$634M | -$923M | -$289M | HZNP, FIXX, AERI, MYL, PTLA | 13F-HR | 11/14/2018, 04:15 PM |
| Q2 2018 | 113 | $2.81B | +$522M | -$724M | -$202M | MNKKQ, HZNP, FIXX, MRTX, MYL | 13F-HR | 8/14/2018, 04:30 PM |
| Q1 2018 | 115 | $2.82B | +$798M | -$540M | +$258M | MNKKQ, MYL, FIXX, HZNP, AVXS | 13F-HR | 5/15/2018, 04:31 PM |
| Q4 2017 | 97 | $2.53B | +$654M | -$453M | +$201M | MNKKQ, MYL, HZNP, DXCM, GKOS | 13F-HR | 2/14/2018, 04:20 PM |
| Q3 2017 | 90 | $2.21B | +$672M | -$396M | +$276M | AVXS, MCK, MYL, HZNP, GKOS | 13F-HR | 11/13/2017, 11:38 AM |
| Q2 2017 | 82 | $1.81B | +$232M | -$1.02B | -$787M | AVXS, HZNP, NXTM, GILD, MYL | 13F-HR | 8/14/2017, 04:02 PM |
| Q1 2017 | 105 | $2.58B | +$529M | -$689M | -$160M | AVXS, HZNP, NXTM, GILD, MYL | 13F-HR | 5/15/2017, 04:03 PM |
| Q4 2016 | 101 | $2.41B | +$647M | -$217M | +$430M | HZNP, NXTM, AVXS, PTLA, GWPH | 13F-HR | 2/14/2017, 05:03 PM |
| Q3 2016 | 90 | $2.15B | +$232M | -$976M | -$744M | GWPH, PTLA, HZNP, NXTM, AVXS | 13F-HR | 11/14/2016, 04:29 PM |
| Q2 2016 | 106 | $2.54B | +$500M | -$461M | +$39.3M | HZNP, NXTM, GWPH, PTLA, AVXS | 13F-HR | 8/15/2016, 10:22 AM |
| Q1 2016 | 105 | $2.33B | +$746M | -$405M | +$341M | HZNP, MYL, NXTM, GSK, AET | 13F-HR | 5/16/2016, 04:05 PM |
| Q4 2015 | 107 | $2.38B | +$370M | -$686M | -$316M | HZNP, NXTM, DYAX, ADPTQ, GSK | 13F-HR | 2/16/2016, 04:01 PM |
| Q3 2015 | 133 | $2.55B | +$594M | -$435M | +$159M | HZNP, NXTM, GSK, AET, FLML | 13F-HR | 11/16/2015, 04:02 PM |
| Q2 2015 | 119 | $2.99B | +$843M | -$1.13B | -$284M | HZNP, FLML, NXTM, ARRY, DYAX | 13F-HR | 8/14/2015, 04:18 PM |
| Q1 2015 | 1 | $1.04M | $0 | $0 | New Holdings | 8/14/2015, 04:16 PM | ||
| Q1 2015 | 121 | $3.06B | +$964M | -$980M | -$16M | ASPX, HZNP, ABBV, NXTM, ARRY | 13F-HR | 5/15/2015, 04:02 PM |
| Q4 2014 | 106 | $2.68B | +$630M | -$922M | -$293M | AUXL, ASPX, HZNP, AGN, FLML | 13F-HR | 2/17/2015, 04:31 PM |
| Q3 2014 | 121 | $2.46B | +$765M | -$481M | +$283M | AUXL, AGN, NXTM, FLML, AAVL | 13F-HR | 11/14/2014, 04:33 PM |
| Q2 2014 | 117 | $2.25B | +$680M | -$687M | -$7.1M | AUXL, ITMN, FLML, AGN, NXTM | 13F-HR | 8/14/2014, 04:33 PM |
| Q1 2014 | 115 | $2.18B | +$832M | -$621M | +$211M | FLML, AUXL, LH, DRNA, QCOR | 13F-HR | 5/15/2014, 04:31 PM |
| Q4 2013 | 98 | $1.77B | $0 | $0 | AUXL, QCOR, ARRY, NXTM, INFI | 13F-HR | 2/14/2014, 04:25 PM |